Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: Results of markov modelling in a european population
Articolo
Data di Pubblicazione:
2009
Citazione:
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: Results of markov modelling in a european population / Cowie, Mr; Marshall, D; Drummond, M; Ferko, N; Maschio, M; Ekman, M; De Roy, L; Heidbuchel, H; Verboven, Y; Braunschweig, F; Linde, C; Boriani, Giuseppe. - In: EUROPACE. - ISSN 1099-5129. - 11:6(2009), pp. 716-726. [10.1093/europace/eup068 ]
Abstract:
Current European guidelines recommend prophylactic implantation of cardioverter defibrillators (ICDs) in patients with a reduced left ventricular ejection fraction (LVEF) who are not in NYHA class IV and have reasonable life expectancy. Cost and benefit implications of this recommendation have not been reported from a European perspective.
Tipologia CRIS:
Articolo su rivista
Keywords:
Cost of Illness; Cost-Benefit Analysis; Death, Sudden, Cardiac; Defibrillators, Implantable; Europe; Female; Humans; Life Expectancy; Male; Markov Chains; Middle Aged; Models, Cardiovascular; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Models, Economic
Elenco autori:
Cowie, Mr; Marshall, D; Drummond, M; Ferko, N; Maschio, M; Ekman, M; De Roy, L; Heidbuchel, H; Verboven, Y; Braunschweig, F; Linde, C; Boriani, Giuseppe
Link alla scheda completa:
Pubblicato in: